A novel study by the Yale School of Public Health unveiled that low doses of aspirin can reduce the risk of developing pancreatic cancer.
Researchers assessed medical records of 1,052 patients for which data was collected from 2005 to 2009. Out of them, 362 were found to be having pancreatic cancer and others did not have the condition.
In the next step, researchers compared aspirinuse of patients and risk of cancer. Researchers noticed those patients who have taken low-dose aspirin for six years or less than that had a 39% reduced risk of developed pancreatic cancer.Patients who took low-dose aspirin for over 10 years had a 60% reduction in the risk of pancreatic cancer. As per researchers, low-dose of aspirin was between 75 and 325 milligrams.
"We found that the use of low-dose aspirin was associated with cutting the risk of pancreatic cancer in half, with some evidence that the longer low-dose aspirin was used, the lower the risk", said Harvey A. Risch, Professor of epidemiology in the Department of Chronic Disease Epidemiology at the Yale School of Public Health in New Haven.
It is vital to find ways to prevent the cancer as around one in 60 adults will get diagnosed with pancreatic cancer and five-year survival rate is less than 5%. LaPook explained aspirin disturbs the inflammatory pathway in the body.
If the pathways that can lead to cancer are interrupted, then the risk for cancer gets lowered. LaPook said they are not completely sure on this, but that is their thought.
People with family history of pancreatic cancer or who have other risk factors for the disease could be at benefit if they take low-dose aspirin, suggest researchers. But they should discuss it with their doctors and then start the medication.
Source:
0 comments:
Post a Comment